Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer

Medical Oncology

Volumn 27, Issue 1, 2010, Pages 91-97

  Kim, Seok Jin ^a,b   Rabbani, Zahid N ^a   Dong, Fan ^a   Vollmer, Robin T ^c   Schreiber, Ernst Gilbert ^d   Dewhirst, Mark W ^a   Vujaskovic, Zeljko ^a   Kelley, Michael J ^a,e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Sungkyunkwan University   (South Korea)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e University of Utah ^*  (United States)

Author keywords

Epidermal growth factor receptor cyclooxygenase 2; Non small cell lung cancer; Phosphorylation; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77949263123     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9178-z     Document Type: Article

References (25)

1. Y Yarden MX Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 127 37 10.1038/35052073 10.1038/35052073 1:CAS:528:DC%2BD3MXivVWnt7k%3D 11252954 (Pubitemid 33674041)
2. J Mendelsohn J Baselga 2003 Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J Clin Oncol 21 2787 99 10.1200/JCO.2003.01.504 10.1200/JCO.2003.01.504 1:CAS:528:DC%2BD2cXptlCktbo%3D 12860957 (Pubitemid 46606324)
3. J Brabender, et al. 2001 Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival Clin Cancer Res 7 1850 5 1:CAS:528:DC%2BD3MXlslaltb8%3D 11448895
4. WW Lai, et al. 2001 Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Ann Thorac Surg 72 1868 76 10.1016/S0003-4975(01)03207-6 10.1016/S0003-4975(01)03207-6 1:STN:280:DC%2BD38%2FmsVWgtw%3D%3D 11789762 (Pubitemid 34001431)
5. M Tateishi, et al. 1990 Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung Cancer Res 50 7077 80 1:CAS:528:DyaK3cXmt1ylu7s%3D 2208175
6. V Rusch, et al. 1997 Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression Clin Cancer Res 3 515 22 1:CAS:528:DyaK2sXislGitLk%3D 9815714
7. RI Nicholson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37 suppl 4 9 15 10.1016/S0959-8049(01)00231-3 10.1016/S0959-8049(01)00231-3
8. R Vadlamudi, et al. 1999 Regulation of cyclooxygenase-2 pathway by HER2 receptor Oncogene 18 305 14 10.1038/sj.onc.1202307 10.1038/sj.onc.1202307 1:CAS:528:DyaK1MXhtFOrsL8%3D 9927187 (Pubitemid 29060606)
9. HS Kim, et al. 2003 Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer Lung Cancer 42 163 70 10.1016/S0169-5002(03)00290-3 10.1016/S0169-5002(03)00290-3 14568683 (Pubitemid 37268026)
10. CM Richardson, et al. 2005 Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer Lung Cancer 48 47 57 10.1016/j.lungcan.2004. 09.007 10.1016/j.lungcan.2004.09.007 1:STN:280:DC%2BD2M7ks1Grsg%3D%3D 15777970 (Pubitemid 40380999)
11. T Kanematsu, et al. 2003 Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients Oncol Res 13 289 98 12688680
12. WA Fry JL Phillips HR Menck 1999 Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report Cancer 86 1867 76 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID- CNCR31>3.0.CO;2-9 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID- CNCR31>3.0.CO;2-9 1:STN:280:DC%2BD3c%2Fhs1eitQ%3D%3D 10547562 (Pubitemid 29513058)
13. SJ Kim, et al. 2004 Carbonic anhydrase IX in early-stage non-small cell lung cancer Clin Cancer Res 10 7925 33 10.1158/1078-0432.CCR-04-0636 10.1158/1078-0432.CCR-04-0636 1:CAS:528:DC%2BD2cXhtVCrs73K 15585626 (Pubitemid 39587532)
14. JG Paez, et al. 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1458 61 10.1126/science. 1099314 (Pubitemid 38720929)
15. Y Yarden 2001 The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities Eur J Cancer 37 suppl 4 3 8 10.1016/S0959-8049(01)00230-1 10.1016/S0959-8049(01)00230-1
16. DS Salomon R Brandt F Ciardiello N Normanno 1995 Epidermal growth factor-related peptides and their receptors in human malignancies Crit Rev Oncol Hematol 19 183 232 10.1016/1040-8428(94)00144-I 10.1016/1040-8428(94)00144-I 1:STN:280:DyaK2Mzjs1KgsQ%3D%3D 7612182
17. J Mendelsohn 2002 Targeting the epidermal growth factor receptor for cancer therapy J Clin Oncol 20 1S 13S 1:CAS:528:DC%2BD38Xot1Ghs70%3D 12235219
18. N Prenzel, et al. 1999 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 884 8 1:CAS:528:DC%2BD3cXitFSltQ%3D%3D 10622253
19. I Vivanco CL Sawyers 2002 The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 489 501 10.1038/nrc839 10.1038/nrc839 1:CAS:528:DC%2BD38XkvFKltLs%3D 12094235
20. CR Weinstein-Oppenheimer, et al. 2000 The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors Pharmacol Ther 88 229 79 10.1016/S0163-7258(00)00085-1 10.1016/S0163-7258(00)00085-1 1:CAS:528:DC%2BD3MXjtFGns7c%3D 11337027 (Pubitemid 32406054)
21. V Calo, et al. 2003 STAT proteins: from normal control of cellular events to tumorigenesis J Cell Physiol 197 157 68 10.1002/jcp.10364 10.1002/jcp.10364 1:CAS:528:DC%2BD3sXntlKkt7k%3D 14502555 (Pubitemid 37485244)
22. RN Jorissen, et al. 2003 Epidermal growth factor receptor: mechanisms of activation and signalling Exp Cell Res 284 31 53 10.1016/S0014-4827(02)00098-8 10.1016/S0014-4827(02)00098-8 1:CAS:528:DC%2BD3sXitVyltr0%3D 12648464 (Pubitemid 36331965)
23. KJ O'Byrne, et al. 2000 Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer Br J Cancer 82 1427 32 10.1054/bjoc.1999.1115 10780522
24. G Cox JL Jones KJ O'Byrne 2000 Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin Cancer Res 6 2349 55 1:CAS:528:DC%2BD3cXksVGhsL4%3D 10873086
25. FR Khuri, et al. 2001 Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer Clin Cancer Res 7 861 7 1:CAS:528:DC%2BD3MXjs1els7o%3D 11309334